Abstract
The predominant symptoms of trisomy 14 mosaicism are prenatal and postnatal growth failure, ear abnormalities, congenital heart disease, developmental delay, and genitourinary abnormalities. Maternal uniparental disomy of chromosome 14 (upd(14)mat) presents discernible clinical features such as prenatal and postnatal growth failure, hypotonia, precocious puberty, and obesity. Given the small number of previously reported patients with a combination of trisomy 14 mosaicism and upd(14)mat, the detailed clinical features of these patients remain to be elucidated. Here we report a severely short-statured girl with feeding difficulties and failure to thrive, ear abnormalities, deafness, small hands, and developmental delay. Karyotyping, FISH analysis, methylation analysis, and microsatellite marker analysis using her leukocytes and buccal cells showed that she had a combination of trisomy 14 mosaicism and upd(14)mat. Furthermore, a comparison of the clinical features of this patient with those of previously reported patients with genetic anomalies including the combination of trisomy 14 mosaicism and upd(14)mat or upd(14)mat suggested that the severe short stature observed in patients with a combination of trisomy 14 mosaicism and upd(14)mat stemmed from the synergic effect of these two events. In severely short-statured patients with trisomy 14 mosaicism, we should be aware of the possible coexistence of upd(14)mat.
Human chromosome 14q32.2 has a cluster of imprinted genes including paternally expressed genes such as DLK1 and RTL1 and maternally expressed genes such as MEG3, RTL1 antisense and MEG8 [1]. The expression of these genes is controlled by the DLK1-MEG3 intergenic differentially methylated region (IG-DMR) and MEG3-DMR [2]. The IG-DMR and MEG3-DMR are methylated after paternal transmission and unmethylated after maternal transmission [3].
Trisomy 14 mosaicism has been reported in approximately 30 patients (Additional file 1). The predominant symptoms of trisomy 14 mosaicism are prenatal and postnatal growth failure, ear abnormalities, congenital heart disease, developmental delay, and genitourinary abnormalities [4,5,6]. Maternal uniparental disomy of chromosome 14 (upd(14)mat) is a condition in which two copies of chromosome 14 are inherited from the mother [7, 8]. Upd(14)mat is one of the genetic causes of Temple syndrome (OMIM 616222) and presents discernible clinical features such as pre- and postnatal growth failure, hypotonia, feeding difficulties, precocious puberty, and obesity [9]. Concomitant trisomy 14 mosaicism and upd(14)mat has been reported in only four patients [10,11,12,13], and its detailed clinical features remain unclear. Here, we report a severely short-statured 3-year-old girl with a concomitant trisomy 14 mosaicism and upd(14)mat.
A 3-year-old Japanese girl was referred to Kurume University hospital due to severe growth failure, failure to thrive, hypotonia, and developmental delay. She was born at 37 weeks of gestation to healthy parents without a family history of genetic diseases. Her birth weight was 2162 g (–1.5SD) and her birth length was 42.7 cm (–2.0SD). She had been admitted to the neonatal intensive care unit for 44 days because of feeding difficulties and failure to thrive. She presented with mild deafness, coloboma, and a small ventricular septal defect but no genitourinary abnormalities. At 3 years of age, her height was 78.8 cm (–5.1SD) and her weight was 8.8 kg (–3.3SD). She showed a hypotonic face, ear abnormalities, deafness, small hands, and closed ventricular septal defect (Fig. 1a, b, Table 1). She was nonverbal and unable to walk at the time. Her plasma hormone levels including thyroid hormone, lutenizing hormone, Follicle-stimulating hormone, and E2 were within the normal range and the GH responses to a provocation test were normal. Her brain magnetic resonance imaging scans showed no abnormalities. To detect the genetic cause of the clinical findings, we first performed karyotyping and detected mosaic 47,XX, + 14[12]/46,XX[88] (Fig. 1c). Subsequently, we performed fluorescence in situ hybridization (FISH) analysis of the leukocytes and the buccal cells using probes for 14q32 at 3 years of age. Trisomy cells were identified in 46.8% of the leukocytes but not in the buccal cells (Fig. 1d). To detect the parental origin of the extra copy of trisomy 14, we performed methylation analysis for the IG-DMR and MEG3-DMR using pyrosequencing as previously reported [14], and identified the mild hypomethylation of these DMRs (Supplementary Table S1). These results indicated that the extra copy of chromosome 14 was inherited from the mother. Next, we performed microsatellite analysis for chromosome 14 using leukocyte DNA samples from the patient and her parents (Supplementary Table S2) and compared the peak area under the curve (AUC) of the maternally-inherited allele to that of the paternally-inherited allele (see Supplementary Methods). In the AUC ratio of D14S292, the patient’s maternally derived peak was significantly higher than the paternally derived peak. Furthermore, the microsatellite data for D14S980 showed three peaks (Fig. 1e). These results indicated that she had a trisomy 14 cell lineage with an extra copy deriving from her mother and a upd(14)mat cell lineage.
Microsatellite analysis for chromosome 14 showed proximal maternal isodisomy and distal maternal heterodisomy (Supplementary Table S2). Figure 2 shows the hypothetical mechanisms by which the trisomy 14 cells and upd(14)mat cells were generated in our patient. The results of microsatellite analysis suggested that crossing over between D14S608 and D14S980 occurred during meiosis I (Supplementary Table S2 and Fig. 2). After fertilization between a diploid oocyte caused by maternal nondisjunction during meiosis II and a normal sperm, the loss of the paternal homologue in a trisomy 14 cell, a condition known as trisomy rescue, leads to a upd(14)mat cell (Fig. 2a). Similarly, the elimination of one maternal chromosome could result in trisomy 14 mosaicism (Fig. 2b). However, the results of the AUC ratio of D14S292 were not consistent with the hypothesis shown in Fig. 2b.
Trisomy 14 cells were detected in 12.0% of the patient’s leukocytes by G-band karyotyping, and in 46.8% of her leukocytes by FISH analysis at age 3 years. We performed FISH analysis again at 6 years of age, and detected trisomy cells in 42.0% of her leukocytes (Fig. 1d). The results of FISH analysis suggested that the proportion of trisomy cells remained unchanged in her leukocytes. The discrepancy between G-band karyotyping and FISH analysis resulting in our patient may be explained by the methodological differences. G-band karyotyping requires that the lymphocytes are cultured with phytohemagglutinin (PHA) to obtain a metaphase image of the chromosomes. A previous report showed that patients with certain chromosomal abnormalities like 21 trisomy were poor responders to PHA [15]. For FISH analysis, no lymphocyte culture is performed. These facts may explain why in our patient the proportion of trisomy cells examined by G-band karyotyping was smaller than that of trisomy cells examined by FISH analysis.
Table 1 compares the clinical features of this patient with two groups: previously reported patients with a combination of trisomy 14 mosaicism [10,11,12,13] and upd(14)mat or patients with upd(14)mat [16]. Global developmental delay was significantly higher in patients with trisomy 14 mosaicism and upd(14)mat than in patients with upd(14)mat, whereas, small hands and/or feet were more frequently seen in patients with upd(14)mat than in patients with trisomy 14 mosaicism and upd(14)mat. Regarding the height SDS, the patients with a combination of trisomy 14 mosaicism and upd(14)mat were significantly shorter than patients with upd(14)mat (Table 1). Severe growth failure, small hands or feet, and global developmental delay are key clinical features of the combination of trisomy 14 mosaicism and upd(14)mat.
Of the five patients with the concomitant trisomy 14 mosaicism and upd(14)mat, our patient was the youngest. Because a high percentage of patients with upd(14)mat present with obesity and precocious puberty after early childhood [9], early genetic diagnosis of trisomy 14 mosaicism with upd(14)mat may be helpful in providing useful information for clinical follow up by drawing attention to symptoms such as obesity and precocious puberty, which become apparent with age.
In summary, we showed that trisomy 14 mosaicism with upd(14)mat led to severe short stature. For severely short-statured patients with trisomy 14 mosaicism, we should be aware of the possible coexistence of upd(14)mat [16].
References
da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC. Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet 2008;24:306–16.
Kagami M, Sekita Y, Nishimura G, Irie M, Kato F, Okada M, et al. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet 2008;40:237–42.
Kagami M, O’Sullivan MJ, Green AJ, Watabe Y, Arisaka O, Masawa N, et al. The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet 2010;6:e1000992.
Fujimoto A, Allanson J, Crowe CA, Lipson MH, Johnson VP. Natural history of mosaic trisomy 14 syndrome. Am J Med Genet 1992;44:189–96.
Hur YJ, Hwang T. Complete trisomy 14 mosaicism: first live-born case in Korea. Korean J Pediatr 2012;55:393–6.
Salas-Labadia C, Lieberman E, Cruz-Alcivar R, Navarrete-Meneses P, Gomez S, Cantu-Reyna C, et al. Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis. Mol Cytogenet 2014;7:65.
Temple IK, Cockwell A, Hassold T, Pettay D, Jacobs P. Maternal uniparental disomy for chromosome 14. J Med Genet 1991;28:511–4.
Hoffmann K, Heller R. Uniparental disomies 7 and 14. Best Pract Res Clin Endocrinol Metab 2011;25:77–100.
Ioannides Y, Lokulo-Sodipe K, Mackay DJ, Davies JH, Temple IK. Temple syndrome: improving the recognition of an underdiagnosed chromosome 14 imprinting disorder: an analysis of 51 published cases. J Med Genet 2014;51:495–501.
Antonarakis SE, Blouin JL, Maher J, Avramopoulos D, Thomas G, Talbot CC Jr. Maternal uniparental disomy for human chromosome 14, due to loss of a chromosome 14 from somatic cells with t(13;14) trisomy 14. Am. J. Hum. Genet. 1993;52:1145–52.
Kayashima T, Katahira M, Harada N, Miwa N, Ohta T, Yoshiura K, et al. Maternal isodisomy for 14q21-q24 in a man with diabetes mellitus. Am J Med Genet 2002;111:38–42.
Balbeur S, Grisart B, Parmentier B, Sartenaer D, Leonard PE, Ullmann U, et al. Trisomy rescue mechanism: the case of concomitant mosaic trisomy 14 and maternal uniparental disomy 14 in a 15-year-old girl. Clin. Case. Rep. 2016;4:265–71.
Zhang S, Qin H, Wang J, OuYang L, Luo S, Fu C, et al. Maternal uniparental disomy 14 and mosaic trisomy 14 in a Chinese boy with moderate to severe intellectual disability. Mol Cytogenet 2016;9:66.
Kagami M, Mizuno S, Matsubara K, Nakabayashi K, Sano S, Fuke T, et al. Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell Syndrome-compatible phenotype. Eur J Hum Genet 2015;23:1062–7.
Serra A, Arpaia E, Bova R. Kinetics of 21-Trisomic Lymphocytes. I. In vitro Response of 21-Trisomic Lymphocytes to PHA. Hum Genet 1978;41:157–67.
Kagami M, Nagasaki K, Kosaki R, Horikawa R, Naiki Y, Saitoh S, et al. Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients. Genet Med 2017; 10.1038/gim.2017.53.
Acknowledgements
We are grateful to the patient and her parents for their cooperation. This work was supported by Grants from the Japan Society for the Promotion of Science (JSPS) (15K15096), the National Center for Child Health and Development (28-6), the Japan Agency for Medical Research and Development (AMED) (16ek0109030h0003, 16ek0109141h0002), The Takeda Science Foundation, and The Japanese Society for Pediatric Endocrinology Future Development Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Ushijima, K., Yatsuga, S., Matsumoto, T. et al. A severely short-statured girl with 47,XX, + 14/46,XX,upd(14)mat, mosaicism. J Hum Genet 63, 377–381 (2018). https://doi.org/10.1038/s10038-017-0381-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-017-0381-z